Page 609 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 26 Tumors of the Endocrine System 587

50. Stolp R, Croughs RJ, Rijnberk A: Results of cyproheptadine treat- 70. Meij BP, van der Vlugt-Meijer RH, van den Ingh TS, et al.: Somato-
ment in dogs with pituitary-dependent hyperadrenocorticism, J troph and corticotroph pituitary adenoma (double adenoma) in a
Endocrinol 101:311–314, 1984. cat with diabetes mellitus and hyperadrenocorticism, J Comp Pathol
VetBooks.ir 51. Castillo V, Giacomini D, Paez-Pereda M, et al.: Retinoic acid as a 71. Cross E, Moreland R, Wallack S: Feline pituitary-dependent hyper-
130:209–215, 2004.
novel medical therapy for Cushing’s disease in dogs, Endocrinology
147:4438–4444, 2006.
52. Meij B, Voorhout G, Rijnberk A: Progress in transsphenoidal adrenocorticism and insulin resistance due to a plurihormonal ade-
noma, Top Companion Anim Med 27:8–20, 2012.
hypophysectomy for treatment of pituitary-dependent hyperad- 72. Sharman M, FitzGerald L, Kiupel M: Concurrent somatotroph
renocorticism in dogs and cats, Mol Cell Endocrinol 197:89–96, and plurihormonal pituitary adenomas in a cat, J Feline Med Surg
2002. 15:945–952, 2013.
53. Meij BP, Voorhout G, van den Ingh TS, et al.: Results of trans- 73. Valentin SY, Cortright CC, Nelson RW, et al.: Clinical findings,
sphenoidal hypophysectomy in 52 dogs with pituitary-dependent diagnostic test results, and treatment outcome in cats with spon-
hyperadrenocorticism, Vet Surg 27:246–261, 1998. taneous hyperadrenocorticism: 30 cases, J Vet Intern Med 28:481–
54. Hanson JM, van ‘t HM, Voorhout G, et al.: Efficacy of transsphe- 487, 2014.
noidal hypophysectomy in treatment of dogs with pituitary-depen- 74. Meij BP, Voorhout G, Van Den Ingh TS, et al.: Transsphenoidal
dent hyperadrenocorticism, J Vet Intern Med 19:687–694, 2005. hypophysectomy for treatment of pituitary-dependent hyperadre-
55. Mamelak AN, Owen TJ, Bruyette D: Transsphenoidal surgery nocorticism in 7 cats, Vet Surg 30:72–86, 2001.
using a high definition video telescope for pituitary adenomas 75. Mayer MN, Greco DS, LaRue SM: Outcomes of pituitary tumor
in dogs with pituitary dependent hypercortisolism: methods and irradiation in cats, J Vet Intern Med 20:1151–1154, 2006.
results, Vet Surg 43:369–379, 2014. 76. Sellon RK, Fidel J, Houston R, et al.: Linear-accelerator-based
56. van Rijn SJ, Galac S, Tryfonidou MA, et al.: The influence of pitu- modified radiosurgical treatment of pituitary tumors in cats: 11
itary size on outcome after transsphenoidal hypophysectomy in a cases (1997-2008), J Vet Intern Med 23:1038–1044, 2009.
large cohort of dogs with pituitary-dependent hypercortisolism, J 77. Duesberg CA, Nelson RW, Feldman EC, et al.: Adrenalectomy for
Vet Intern Med 30:989–995, 2016. treatment of hyperadrenocorticism in cats: 10 cases (1988-1992), J
57. Del Magno S, Grinwis GCM, Voorhout G, et al.: Dynamic com- Am Vet Med Assoc 207:1066–1070, 1995.
puted tomography of the pituitary gland using a single slice scan- 78. Skelly BJ, Petrus D, Nicholls PK: Use of trilostane for the treat-
ner in dogs with pituitary-dependent hypercortisolism, Res Vet Sci ment of pituitary-dependent hyperadrenocorticism in a cat, J Small
107:42–49, 2016. Anim Pract 44:269–272, 2003.
58. Sato A, Teshima T, Ishino H, et al.: A magnetic resonance imag- 79. Neiger R, Witt AL, Noble A, et al.: Trilostane therapy for treatment
ing-based classification system for indication of trans-sphenoidal of pituitary-dependent hyperadrenocorticism in 5 cats, J Vet Intern
hypophysectomy in canine pituitary-dependent hypercortisolism, J Med 18:160–164, 2004.
Small Anim Pract 57:240–246, 2016. 80. Mellett Keith AM, Bruyette D, Stanley S: Trilostane therapy for
59. Kooistra HS, Voorhout G, Mol JA, et al.: Correlation between treatment of spontaneous hyperadrenocorticism in cats: 15 cases
impairment of glucocorticoid feedback and the size of the pituitary (2004-2012), J Vet Intern Med 27:1471–1477, 2013.
gland in dogs with pituitary-dependent hyperadrenocorticism, J 81. Peterson ME, Taylor RS, Greco DS, et al.: Acromegaly in 14 cats, J
Endocrinol 152:387–394, 1997. Vet Intern Med 4:192–201, 1990.
60. van Rijn SJ, Hanson JM, Zierikzee D, et al.: The prognostic value 82. Hurty CA, Flatland B: Feline acromegaly: a review of the syn-
of perioperative profiles of ACTH and cortisol for recurrence after drome, J Am Anim Hosp Assoc 41:292–297, 2005.
transsphenoidal hypophysectomy in dogs with corticotroph adeno- 83. Reusch CE: Disorders of Growth Hormone. In Feldman EC, Nel-
mas, J Vet Intern Med 29:869–876, 2015. son RW, Reusch CE, et al.: Canine and feline endocrinology, ed 4,
61. Dow SW, Lecouteur RA, Rosychuk RAW, et al.: Response of dogs St. Louis, 2015, Elsevier, pp 37–76.
with functional pituitary macroadenomas and macrocarcinomas to 84. Scudder CJ, Niessen SJ, Catchpole B, et al.: Feline hypersomatot-
radiation, J Small Anim Pract 31:287–294, 1990. ropism and acromegaly tumorigenesis: a potential role for the AIP
62. Goossens MM, Feldman EC, Nelson RW, et al.: Cobalt 60 irradia- gene, Domest Anim Endocrinol 59:134–139, 2017.
tion of pituitary gland tumors in three cats with acromegaly, J Am 85. Niessen SJ, Church DB, Forcada Y: Hypersomatotropism, acro-
Vet Med Assoc 213:374–376, 1998. megaly, and hyperadrenocorticism and feline diabetes mellitus, Vet
63. De Fornel P, Delisle F, Devauchelle P, et al.: Effects of radiother- Clin North Am Small Anim Pract 43:319–350, 2013.
apy on pituitary corticotroph macrotumors in dogs: a retrospective 86. Niessen SJ, Petrie G, Gaudiano F, et al.: Feline acromegaly: an
study of 12 cases, Can Vet J 48:481–486, 2007. underdiagnosed endocrinopathy? J Vet Intern Med 21:899–905,
64. Marcinowska A, Warland J, Brearley M, et al.: Comparison of 2007.
two coarse fractionated radiation protocols for the management of 87. Niessen SJ, Forcada Y, Mantis P, et al.: Studying cat (Felis catus) dia-
canine pituitary macrotumor: an observational study of 24 dogs, betes: beware of the acromegalic imposter, PloS one 10:e0127794,
Vet Radiol Ultrasound 56:554–562, 2015. 2015.
65. Sawada H, Mori A, Lee P, et al.: Pituitary size alteration and 88. Schaefer S, Kooistra HS, Riond B, et al.: Evaluation of insulin-like
adverse effects of radiation therapy performed in 9 dogs with pitu- growth factor-1, total thyroxine, feline pancreas-specific lipase and
itary-dependent hypercortisolism, Res Vet Sci 118:19–26, 2018. urinary corticoid-to-creatinine ratio in cats with diabetes mellitus
66. Feldman EC: Hyperadrenocorticism in cats. In Feldman EC, Nel- in Switzerland and the Netherlands, J Feline Med Surg 19:888–896,
son RW, Reusch CE, et al.: Canine and feline endocrinology, ed 4, 2017.
St. Louis, 2015, Elsevier, pp 452–484. 89. Peterson ME: Acromegaly in cats: are we only diagnosing the tip of
67. Ramsey IK, Herrtage ME: Feline hyperadrenocorticism. In Ettinger the iceberg? J Vet Intern Med 21:889–891, 2007.
SJ, Feldman EC, Cote E, editors: Textbook of veterinary internal 90. Berg RI, Nelson RW, Feldman EC, et al.: Serum insulin-like
medicine, ed 8, St. Louis, 2017, Elsevier, pp 1811–1818. growth factor-1 concentration in cats with diabetes mellitus and
68. Boland LA, Barrs VR: Peculiarities of feline hyperadrenocorticism: acromegaly, J Vet Intern Med 21:892–898, 2007.
update on diagnosis and treatment, J Feline Med Surg 19:933–947, 91. Norman EJ, Mooney CT: Diagnosis and management of diabetes
2017. mellitus in five cats with somatotrophic abnormalities, J Feline Med
69. Kimitsuki K, Boonsriroj H, Kojima D, et al.: A case report of feline Surg 2:183–190, 2000.
pituitary carcinoma with hypercortisolism, J Vet Med Sci 76:133– 92. Niessen SJ: Feline acromegaly: an essential differential diagnosis for
138, 2014. the difficult diabetic, J Feline Med Surg 12:15–23, 2010.